1.15

1.71% -0.02

Opko Health Inc (OPK)

Overview News Price History Option Chain Financials Why OPK Down? Discussions Forecast

Opko Health Inc stock is traded at $1.15, with a volume of 759.13K. It is down -1.71% in the last 24 hours and down -4.17% over the past month. OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Previous Close:

$1.17

Open:

$1.16

24h Volume:

759.13K

Relative Volume:

0.25

Market Cap:

$872.93M

Revenue:

$606.88M

Net Income/Loss:

$-225.68M

P/E Ratio:

-3.8054

EPS:

-0.3022

Net Cash Flow:

$-190.82M

1W Performance:

-3.36%

1M Performance:

-4.17%

6M Performance:

-20.69%

1Y Performance:

-36.81%

1-Day Range:

$1.1401

$1.1759

1-Week Range:

$1.1401

$1.22

52-Week Range:

$1.11

$1.8275

Opko Health Inc Stock (OPK) Company Profile

Name

Opko Health Inc

Sector

Healthcare (1117)

Industry

Diagnostics & Research (53)

Phone

305-575-4181

Address

4400 BISCAYNE BLVD., MIAMI, FL

Employee

2,275

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

OPK's Discussions on Twitter

Compare OPK vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OPK Opko Health Inc	1.15	888.11M	606.88M	-225.68M	-190.82M	-0.3022
TMO Thermo Fisher Scientific Inc	474.27	174.68B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	190.47	134.43B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	578.19	46.17B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	112.09	31.58B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	300.62	29.39B	3.17B	642.63M	516.49M	10.77

Opko Health Inc Stock (OPK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-20-25	Initiated	JP Morgan	Neutral
Oct-31-25	Downgrade	Jefferies	Buy → Hold
Apr-25-25	Initiated	JP Morgan	Neutral
Jun-29-23	Upgrade	Barrington Research	Mkt Perform → Outperform
Dec-15-22	Initiated	H.C. Wainwright	Buy
Jan-24-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Jun-21-21	Initiated	Ladenburg Thalmann	Buy
Nov-25-19	Initiated	Piper Jaffray	Overweight
Mar-02-18	Downgrade	JP Morgan	Neutral → Underweight
Sep-14-17	Downgrade	JP Morgan	Overweight → Neutral
Jun-21-16	Reiterated	Standpoint Research	Buy
Jun-03-16	Initiated	Standpoint Research	Buy
Mar-31-16	Reiterated	Barrington Research	Outperform
Oct-16-15	Initiated	JP Morgan	Overweight
Sep-11-15	Downgrade	Jefferies	Buy → Hold
Mar-03-15	Downgrade	Oppenheimer	Outperform → Perform
May-12-14	Reiterated	Oppenheimer	Outperform
Mar-14-14	Initiated	Oppenheimer	Outperform
Nov-13-13	Reiterated	Ladenburg Thalmann	Buy
May-30-13	Reiterated	Ladenburg Thalmann	Buy
Oct-22-12	Initiated	Barrington Research	Outperform
Dec-01-11	Reiterated	Ladenburg Thalmann	Buy
Jul-14-11	Initiated	Ladenburg Thalmann	Buy

View All

Opko Health Inc Stock (OPK) Latest News

01:18 AM

OPKO Health Appoints Subbarao V. Uppaluri, Ph.D. as New Director – SEC 8-K Filing March 2026 - Minichart

01:18 AM

Mar 19, 2026

OPKO Health appoints Subbarao V. Uppaluri to board of directors - Investing.com

Mar 19, 2026

Opko Health Adds Independent Director to Strengthen Governance - TipRanks

Mar 19, 2026

OPKO appoints Subbarao V. Uppaluri to Board following Richard Krasno's passing - TradingView

Mar 19, 2026

Aug Ideas: Is OPKO Health Inc stock forming a cup and handleQuarterly Profit Review & Daily Momentum Trading Reports - baoquankhu1.vn

Mar 18, 2026